<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-molecules-25-04878">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gills</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>LoPiccolo</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Tsurutani</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Shoemaker</surname>
    <given-names>R.H.</given-names>
   </name>
   <name>
    <surname>Best</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Abu-Asab</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Borojerdi</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Warfel</surname>
    <given-names>N.A.</given-names>
   </name>
   <name>
    <surname>Gardner</surname>
    <given-names>E.R.</given-names>
   </name>
   <name>
    <surname>Danish</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo</article-title>
  <source>Clin. Cancer Res.</source>
  <year>2007</year>
  <volume>13</volume>
  <fpage>5183</fpage>
  <lpage>5194</lpage>
  <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-07-0161</pub-id>
  <pub-id pub-id-type="pmid">17785575</pub-id>
 </element-citation>
</ref>
